Found: 5
Select item for more details and to access through your institution.
Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 742, doi. 10.1002/cpdd.672
- By:
- Publication type:
- Article
Urinary dipeptidyl peptidase‐4 protein is increased by linagliptin and is a potential predictive marker of urine albumin‐to‐creatinine ratio reduction in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1968, doi. 10.1111/dom.14407
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of BI 187004, an inhibitor of 11beta-hydroxysteroid dehydrogenase-1, in healthy male volunteers with overweight or obesity.
- Published in:
- Clinical Diabetes & Endocrinology, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40842-021-00130-x
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 3, p. 327, doi. 10.1007/s00228-012-1304-8
- By:
- Publication type:
- Article
Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 6, p. 1317, doi. 10.1007/s13300-020-00819-9
- By:
- Publication type:
- Article